Abstract
Increases in the activities of human circulatory ribonucleases have been associated with malignancies and other pathological conditions. To elucidate the relationship between circulatory ribonuclease and pancreatic malignancy, we have determined the activities in serum of ribonucleases selective for polycytidylic acid (ribonuclease C) and of α-amylase before and after surgery for pancreatic cancer and for several malignant and nonmalignant disorders unrelated to the pancreas. Prior to pancreatectomy, the activity of ribonuclease C in the serum of three pancreatic cancer patients was within the range of values obtained for healthy subjects. Unexpectedly, ribonuclease C began to increase within 2 hr after surgery, and amounts of ribonuclease C more than threefold higher than preoperative levels were found for at least 3 weeks after pancreatectomy. Variations in the serum concentrations of urea nitrogen and creatinine followed time courses which differed from those of ribonuclease C; thus the increases in the activity of ribonuclease C could not be attributed to renal impairment. The concentrations of α-amylase and trypsinogen in the blood of two of the pancreatic cancer patients were considerably higher than those of healthy subjects and declined rapidly to subnormal levels after pancreatectomy. Only a small amount of α-amylase and no trypsinogen were found in the blood of the third patient both before and after surgery, and samples of pure pancreatic juice obtained preoperatively after sequential intravenous administration of secretin and cholecystokinin-pancreozymin were negative for α-amylase and three proteolytic zymogens; nevertheless, the presurgical level of ribonuclease C in his serum was within the normal range. For all of the patients treated for nonpancreatic disorders, the concentrations of ribonuclease C and α-amylase in serum were not significantly altered by surgery. The rate and ultimate extent of the decrease in circulatory α-amylase following pancreatectomy indicate that ≈-80% of the α-amylase in blood is pancreatic in origin and that the half-life of pancreatic α-amylase in the peripheral circulation ≈-15 hr. From the highly significant increases in circulatory ribonuclease C which followed pancreatectomy for pancreatic cancer, we conclude that the exocrine pancreas is neither the sole nor the principal source of ribonuclease C in the peripheral circulation.
Similar content being viewed by others
References
Warshaw AL, Lee K-H: Serum ribonuclease elevations and pancreatic necrosis in acute pancreatitis. Surgery 86:227–234, 1979
Rabinovitch M, Liberman B, Fausto N: Plasma ribonuclease activity in human uremia. J Lab Clin Med 53:563–568, 1959
Peterson LM: Serum RNase in the diagnosis of pancreatic carcinoma. Proc Natl Acad Sci USA 76:2630–2634, 1979
Akagi K, Yamanaka M, Murai K, Omae T: Purification and properties of acid ribonucleases in human serum and leukocytes. Cancer Res 38:2163–2167, 1978
Sheid B, Lu T, Pedrinan L, Nelson JH: Plasma ribonuclease. A marker for the detection of ovarian cancer. Cancer 39:2204–2208, 1978
Reddi KK, Holland JF: Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci USA 73:2308–2310, 1976
Warshaw AL, Lee K-H, Wood WC, Cohen AM: Sensitivity and specificity of serum ribonuclease in the diagnosis of pancreatic cancer. Am J Surg 139:27–32, 1980
Reddi KK: Nature and possible origin of human serum ribonuclease. Biochem Biophys Res Commun 67:110–118, 1975
Isaacs P: Serum ribonuclease (c-RNase): Evidence against pancreatic tumor specificity. Ir J Med Sci 146(suppl 1):38–39, 1977
Abramson SB, Renner IG: Human ribonucleases selective for polycytidylic acid: Evidence for catalytic heterogeneity and nonpancreatic origin of ribonucleases in human serum. J Cell Biol 87:327a, 1980 (abstract)
Zimmerman SB, Sandeen G: A sensitive assay for pancreatic ribonuclease. Anal Biochem 10:444–449, 1965
Rinderknecht H: A rapid, simple method for estimating plasma trypsinogen. Clin Res 28:631A, 1980 (abstract)
Rinderknecht H, Renner IG, Carmack C: Activation of human pancreatic juice. Clin Chim Acta 73:369–372, 1976
Rinderknecht H, Fleming RM: A new, highly sensitive and specific assay for chymotrypsin. Clin Chim Acta 59:139–146, 1975
Rinderknecht H, Renner IG, Douglas AP, Adham NF: Profiles of pure pancreatic secretions obtained by direct pancreatic duct cannulation in normal healthy human subjects. Gastroenterology 75:1083–1089, 1978
Dixon WJ, Massey FJ Jr: Introduction to Statistical Analysis, 3rd ed., New York, McGraw-Hill, 1969
Migliarese JF: Serum ribonuclease in the cancer patient. Proc Am Assoc Cancer Res 2:327, 1958 (abstract)
Maor D, Mardiney MR Jr: Alteration of human serum ribonuclease activity in malignancy. CRC Rev Clin Lab Sci 10:89–111, 1979
Daoust R, Amano H: Ribonuclease and deoxyribonuclease activities in experimental and human tumors by the histochemical substrate film method. Cancer Res 23:131–134, 1963
Taper HS, Brucher J-M, Fort L: Activity of alkaline and acid nucleases in tumors of the nervous system. Cancer 28:482–490, 1971
Fontaniére B, Daoust R: Histochemical studies on nuclease activity and neoplastic transformation in rat liver during diethylnitrosamine carcinogenesis. Cancer Res 33:3108–3111, 1973
Roth JS, Hilton S, Morris HP: Ribonuclease activity in some transplantable rat hepatomas. Cancer Res 24:294–301, 1964
Chakravorty AK, Busch H: Alkaline ribonuclease and ribonuclease inhibitor in nuclear and nucleolar preparations from normal and neoplastic tissue. Cancer Res 27:789–792, 1967
Ambellan E, Hollander VP: The role of ribonuclease in regression of lymphoma P1798, Cancer Res 26:903–909, 1966
Graffi A, Arnold W: Inhibition by pancreatic ribonuclease of experimental tumor metastisizing in mice. Acta Biol Med Ger 30:K15-K18, 1973
Erbe W, Preiss J, Siefert R, Hilz H: Increase in RNase and DPNase activities in ascites tumor cells induced by various cytostatic agents. Biochem Biophys Res Commun 23:392–397, 1966
Goldberg DM, Ayre HA, Pitts JF: Effect of radium treatment on activity and distribution of some enzymes in cancers of the human cervix uteri. Cancer 20:1388–1394, 1967
Zigman S, Allison JB: Ribonuclease activity of protein-depleted and tumor-bearing rats. Cancer Res 10:1105–1108, 1959
Allison JB, Wannemacher RW Jr, Banks WL, Wunner WH, Gomez-Brenes RA: Dietary proteins correlated with ribonuclease, ribonucleic acid and tissue proteins. J Nutr 78:333–337, 1962
Albanese AA, Orto LA, Zavarotto DN, De Carlo R: Protein metabolic significance of blood ribonuclease levels in man. Nutr Rep Int 4:151–164, 1971
Scott PH, Berger HM, Kenward C, Scott P, Wharton BA: Plasma alkaline ribonuclease (EC 3.1.4.22) and nitrogen retention in low-birth-weight infants. Br J Nutr 40:459–464, 1978
Levy AL, Rottino A: Effect of disease states on the ribonuclease concentration of body fluids. Clin Chem 6:43–51, 1960
Zytko J, Cantero A: Serum ribonuclease in patients with malignant disease. Can Med Assoc J 86:482–485, 1962
Shenkin A, Citrin DL, Rowan RM: An assessment of the clinical usefulness of plasma ribonuclease assays. Clin Chim Acta 72:223–231, 1976
Kottel RH, Hoch SO, Parsons RG, Hoch JA: Serum ribonuclease activity in cancer patients. Br J Cancer 38:280–286, 1978
Mackie CR, Moossa AR, Go VLW, Noble G, Sizemore G, Cooper MJ, Wood RAB, Hall AW, Waldmann T, Gelder F, Rubenstein AH: Prospective evaluation of some candidate tumor markers in the diagnosis of pancreatic cancer. Dig Dis Sci 25:161–172, 1980
Duane WC, Frerichs R, Levitt MD: Simultaneous study of the metabolic turnover and renal excretion of salivary amylase-125I and pancreatic amylase-131I in the baboon. J clin Invest 51:1504–1513, 1972
Duane WC, Frerichs R, Levitt MD: Distribution, turnover and mechanism of renal excretion of amylase in the baboon. J Clin Invest 50:156–165, 1971
Skude G: Human amylase isoenzymes. Scand J Gastroenterol 12(suppl 44), 1977
O'Donnell MD, McGeeney KF: Purification and properties of an α-amylase inhibitor from wheat. Biochim Biophys Acta 422:159–169, 1976
O'Donnell MD, FitzGerald O, McGeeney KF: Differential serum amylase determination by use of an inhibitor, and design of a routine procedure. Clin Chem 23:560–566, 1977
O'Donnell MD, Miller MJ: Plasma pancreatic and salivary type amylase and immunoreactive trypsin concentrations: Variations with age and reference ranges for children. Clin Chim Acta 104:265–273, 1980
Lorentz K: Salivary isoamylases: Deamidation products of amylase. Clin Chim Acta 93:161–162, 1979
Abramson SB, Renner IG, Douglas AP: Multiple molecular forms of α-amylase from pure human pancreatic juice: Kinetics and possible mechanisms of generation. ASCB Methods Perspectives Cell Biol Proc Symp 1979, in press (abstract)
Warshaw AL, Lee K-H: Aging changes of pancreatic isoamylases and the appearance of “old amylase” in the serum of patients with pancreatic pseudocysts. Gastroenterology 79:1246–1251, 1980
Author information
Authors and Affiliations
Additional information
This work was supported in part by a grant from the Robert E. and May R. Wright Foundation and by grant CA 20222 from the National Pancreatic Cancer Project, National Cancer Institute, Department of Health and Human Services.
Rights and permissions
About this article
Cite this article
Abramson, S.B., Rinderknecht, H. & Renner, I.G. Ribonuclease C and pancreatic secretory proteins in the peripheral circulation before and after pancreatectomy for pancreatic cancer. Digest Dis Sci 27, 889–896 (1982). https://doi.org/10.1007/BF01316572
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01316572